A previous study using transcriptomic functional annotation and protein–protein interacting network analyses demonstrated that the histone-lysine N-methyltransferase (EZH2) and UBE2C were identified as principal interacting proteins of druggable networks [18], implying that the EZH2–UBE2C interaction may be critical for cancer progression. Here, UBE2C is linked to cancer.